Trials / Active Not Recruiting
Active Not RecruitingNCT06302608
Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy
Clinical Trial on the Safety and Effectiveness of Subretinal Injection of NGGT001 for Treating Crystalline Retinal Degeneration
- Status
- Active Not Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Xiamen Ophthalmology Center Affiliated to Xiamen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety and tolerability of NGGT001 subretinal injection for the treatment of crystalline retinal degeneration (BCD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | NGGT001 | Safety and Effectiveness of subretinal injection of NGGT001 for treating crystalline retinal degeneration |
Timeline
- Start date
- 2023-02-08
- Primary completion
- 2024-05-29
- Completion
- 2028-05-29
- First posted
- 2024-03-12
- Last updated
- 2024-03-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06302608. Inclusion in this directory is not an endorsement.